|
Crioestaminal - Saúde e Tecnologia, SA, was founded in 2003, becoming the first umbilical cord blood bank in the Iberian Peninsula.〔(Crioestaminal - Saúde e Tecnologia, SA )〕 Since then, it has developed into the largest Portuguese and one of the five largest cryo-preservation banks in Europe with over 60,000 stored samples. Crioestaminal was the first company to be authorized by the Portuguese Ministry of Health and is the only family bank with an AABB (American Association of Blood Banks) accreditation in Portugal. In Europe, there are only five banks with an AABB accreditation.〔(AABB - American Association of Blood Banks )〕 ==History== Crioestaminal was founded by a group of scientists and health care professionals in 2003. In 2006, Crioestaminal opened its state-of-the-art laboratory in the Biocant Park, Portugal first Biotechnology Park. During the same year, Crioestaminal founded a company focused molecular biology diagnostics: ''Genelab – Diagnóstico Molecular''. In 2007, Crioestaminal released a first sample to be used in a transplant. The cord blood stem cells were used to treat a child with Severe combined immunodeficiency (SCID). The sample belonged to the child’s sibling and had been stored since 2003. In 2009, (The Riverside Group ) became the company’s main shareholder. During the last years, the US investment company has contributed to Crioestaminal’s growth in Portugal and abroad. Crioestaminal acquired (''Celvitae'' ), a Spanish company, in 2010 to strengthen its presence in the neighboring country. In 2013, Crioestaminal announced a new investment project that will transform the company into the second-largest cord blood and tissue cryopreservation bank in Europe by storage capacity. During the same year, the company won the customer choice award ''Escolha do Consumidor''. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Crioestaminal」の詳細全文を読む スポンサード リンク
|